Up to now, the relationship between CCN2 and ABCG1 in the maintenance of HCC oxaliplatin resistance, and the role and mechanism of IP6 in reversing oxaliplatin resistance are still vague. This evidence concerns the gene ABCG1 and hepatocellular carcinoma.